These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 19460759)
21. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152 [TBL] [Abstract][Full Text] [Related]
22. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease. Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062 [TBL] [Abstract][Full Text] [Related]
23. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer. Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182 [TBL] [Abstract][Full Text] [Related]
24. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers. Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117 [TBL] [Abstract][Full Text] [Related]
25. Gab2 is a novel prognostic factor for colorectal cancer patients. Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784 [TBL] [Abstract][Full Text] [Related]
26. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer. Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477 [TBL] [Abstract][Full Text] [Related]
27. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics. Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327 [TBL] [Abstract][Full Text] [Related]
28. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer. Liu C; Pan C; Shen J; Wang H; Yong L Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268 [TBL] [Abstract][Full Text] [Related]
29. Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis. He Y; Mou Z; Li W; Liu B; Fu T; Zhao S; Xiang D; Wu Y Int J Colorectal Dis; 2009 Nov; 24(11):1271-9. PubMed ID: 19597826 [TBL] [Abstract][Full Text] [Related]
30. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Wu C; Luo Z; Chen X; Wu C; Yao D; Zhao P; Liu L; Shi B; Zhu L Oncol Rep; 2009 Jun; 21(6):1429-37. PubMed ID: 19424620 [TBL] [Abstract][Full Text] [Related]
31. Proteomic Profiling for Colorectal Cancer Biomarker Discovery. Álvarez-Chaver P; De Chiara L; Martínez-Zorzano VS Methods Mol Biol; 2018; 1765():241-269. PubMed ID: 29589313 [TBL] [Abstract][Full Text] [Related]
32. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer. Zou G; Wang R; Wang M Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664 [TBL] [Abstract][Full Text] [Related]
33. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer. Wu HK; Liu C; Fan XX; Wang H; Zhou L Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451 [TBL] [Abstract][Full Text] [Related]
34. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. O'Dwyer D; Ralton LD; O'Shea A; Murray GI PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer. Shen X; Han J J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894 [TBL] [Abstract][Full Text] [Related]
36. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance. Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500 [TBL] [Abstract][Full Text] [Related]
37. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627 [TBL] [Abstract][Full Text] [Related]
38. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966 [TBL] [Abstract][Full Text] [Related]
39. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study]. Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385 [TBL] [Abstract][Full Text] [Related]
40. Identification of Rho GTPase activating protein 6 isoform 1 variant as a new molecular marker in human colorectal tumors. Guo F; Liu Y; Huang J; Li Y; Zhou G; Wang D; Li Y; Wang J; Xie P; Li G Pathol Oncol Res; 2010 Sep; 16(3):319-26. PubMed ID: 19960375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]